scholarly article | Q13442814 |
P50 | author | Tai-Tong Wong | Q38641665 |
Yu-Wen Hu | Q54678697 | ||
P2093 | author name string | Yi-Wei Chen | |
Kai-Ping Chang | |||
Hsin-Hung Chen | |||
Feng-Chi Chang | |||
Yi-Yen Lee | |||
Wan-Yuo Guo | |||
Muh-Lii Liang | |||
Donald Ming-Tak Ho | |||
Sang-Hue Yen | |||
I-Chun Lai | |||
Cheng-Ying Shiau | |||
P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study | Q28296725 | ||
Intracranial germ-cell tumors in children | Q33335031 | ||
Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group | Q33863188 | ||
Pediatric central nervous system germ cell tumors: a review | Q34012518 | ||
Controversies in the management of intracranial germ cell tumors. | Q36439649 | ||
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation f | Q36866034 | ||
Update on current standard treatments in central nervous system germ cell tumors | Q37795525 | ||
Delayed diagnosis in children with intracranial germ cell tumors | Q38125017 | ||
Intracranial germ-cell tumors: natural history and pathogenesis | Q39495486 | ||
Treatment of germ cell tumors in the pineal region | Q42453836 | ||
Chemotherapy with cisplatin for AFP-secreting germ-cell tumors of the central nervous system | Q42487343 | ||
Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study. | Q43197920 | ||
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group | Q43444624 | ||
Combined chemotherapy and radiation therapy for CNS germ cell tumors--the Japanese experience | Q44465717 | ||
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors | Q44767134 | ||
Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol | Q44780578 | ||
AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. | Q46431239 | ||
The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal group | Q48122879 | ||
Prognosis of intracranial germ cell tumours: Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16) | Q48391650 | ||
Evidence of changes in regional blood perfusion in human intracranial tumours during conductive interstitial hyperthermia | Q48417096 | ||
An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Société Française d'Oncologie Pédiatrique | Q48497303 | ||
Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy | Q48793236 | ||
Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases | Q48794091 | ||
Change in treatment strategy for intracranial germinoma: long-term follow-up experience at a single institute | Q48849587 | ||
The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors | Q48919893 | ||
Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy. | Q53126862 | ||
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors. | Q53286536 | ||
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy. | Q53326085 | ||
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. | Q53576437 | ||
[Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a phase II study--The Japanese Intracranial Germ Cell Tumor Study Group] | Q68976833 | ||
Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89 | Q80156987 | ||
P433 | issue | 5 | |
P304 | page(s) | 683-691 | |
P577 | publication date | 2015-03-08 | |
P1433 | published in | Child's Nervous System | Q15762919 |
P1476 | title | Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience | |
P478 | volume | 31 |
Q47646794 | Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors |
Q92433375 | Immature teratoma of the posterior fossa in an infant: case report |
Q55082765 | Intracranial Germ Cell Tumor in the Molecular Era. |
Search more.